commercializing a new source of bioactives - Fully Protected at the source and already at scale with 2000 plus tonnes available and exclusive. Anti inflammatory and anti oxidant clinicals already completed showing Reduction in systematic and responsive inflamation in ingesteble and topical applicati...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2022 (2 years) |
Funding status Private |
Company type SME |